Related references
Note: Only part of the references are listed.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review
Alexandra McAleenan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans
Jurgen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem
David C. Griffith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli
Nicholas M. Smith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacodynamics of teicoplanin against MRSA
V. Ramos-Martin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacodynamics of colistin and fosfomycin: a 'treasure trove' combination combats KPC-producing Klebsiella pneumoniae
Miao Zhao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model
Renu Singh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model
Brian D. VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates
V. Ramos-Martin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
Neang S. Ly et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Evaluation of Meropenem Regimens Suppressing Emergence of Resistance in Acinetobacter baumannii with Human Simulated Exposure in an In Vitro Intravenous-Infusion Hollow-Fiber Infection Model
Xin Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
PK/PD models in antibacterial development
Tony Velkov et al.
CURRENT OPINION IN MICROBIOLOGY (2013)
Front-Loaded Linezolid Regimens Result in Increased Killing and Suppression of the Accessory Gene Regulator System of Staphylococcus aureus
Brian T. Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
Elizabeth B. Hirsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Visualization of Abscess Formation in a Murine Thigh Infection Model of Staphylococcus aureus by 19F-Magnetic Resonance Imaging (MRI)
Tobias Hertlein et al.
PLOS ONE (2011)
Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model
Andres F. Zuluaga et al.
PLOS ONE (2010)
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures
R Schaumann et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2005)
Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model
PK Dandekar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Industrial choices for protein production by large-scale cell culture
L Chu et al.
CURRENT OPINION IN BIOTECHNOLOGY (2001)
Share Paper
